Filter posts

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

IP Sessions at BIO 2015: The Evolving Landscape of Patentable Subject Matter

The IP Track at BIO 2015 had a number of incredible educational sessions concerning the …

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

IP Sessions at the 2015 BIO International Convention

This year’s BIO International Convention will be host to educational sessions on the latest issues …

Inventors of Life-Saving Golden Rice Receive Prestigious Patents for Humanitarian Award

On Monday, April 21, 2015, the White House Office of Science and Technology Policy and the …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

Kyle Bass Files Second IPR Petition

Today hedge fund manager Kyle Bass has continued his reported “short activist strategy” campaign by …

When The Deck is Stacked Against Innovators, Everyone Loses

Yesterday, I took part in a series of successful meetings on Capitol Hill regarding the …

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …

USPTO Issues New Myriad Guidance

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …